Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-02-06
2007-02-06
Aulakh, Charanjit S. (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S015000
Reexamination Certificate
active
11028281
ABSTRACT:
The present invention relates to compounds of formulawhereinA-B is —CH2—CH2—, —CH2—O— or —O—CH2—;X is hydrogen or hydroxy;R1is aryl, optionally substituted by one or two substituents selected from the group consisting of halogen, lower alkyl, cyano, CF3, —OCF3, lower alkoxy, —SO2-lower alkyl and heteroaryl;R2is aryl, optionally substituted by one or two substituents selected from the group consisting of halogen, lower alkyl, CF3, and lower alkoxy;R3is hydrogen or lower alkyl;n is0, 1or2;or a pharmaceutically active salt thereof.The compounds of the invention may be used in the treatment of neurological and neuropsychiatric disorders.
REFERENCES:
patent: WO 01/94346 (2001-12-01), None
patent: WO 03/010138 (2003-02-01), None
patent: WO 03/049741 (2003-06-01), None
Lewis D. A. et al., Neuron, 2000, vol. 28, pp. 325-334.
Vandenberg R. J., et al., Exp. Opin. Ther. Targets, 2001, vol. 5(4) pp. 507-518.
Nakazato A. et al., 2000, Exp. Opin. Ther. Patents vol. 10(1) pp. 75-98.
Sharma T., Br. J. Psychiatry, 1999, vol. 174 (Suppl. 28) pp. 44-51.
Javitt D.C., 1999, Biol. Psychiatry, vol. 45, pp. 668-679.
Mohn A. R. et al., 1999, Cell, vol. 98, pp. 427-436.
Bliss, T. V. et al., 1993, Nature, vol. 361 pp. 31-39.
Tang J. P. et al., 1999, Nature, vol. 401, pp. 63-69.
Gainetdinov R. R. et al., 2002, Trends in Pharm. Sci. vol. 23(8) pp. 367-373.
Lopez-Corcuera B. et al., 2001, Mol. Mem. Biol. vol. 18, pp. 13-20.
Bergeron R. et al., 1998, Proc. Natl. Acad. Sci. USA, vol. 95, pp. 15730-15734.
Chen, L. et al., 2003, J. Neurophysiol. vol. 89(2) pp. 691-703.
Armer R. E. et al., 2001, Exp. Opin. Ther. Patents vol. 11(4) pp. 563-572.
Pralong E. T. et al., 2002, Prog. Neurobiol. vol. 67, pp. 173-202.
Carlsson M. L. 1998, J. Neurol. Transm. vol. 105, pp. 525-535.
Jonas Bortrom, et al.,A 3d qsar study on a set of dopamine d4 receptor antagonists, J.Chem. Inf. Comp. Sci, vol. 43, pp. 1020-1027 (2003), XP002272148.
Ceccarelli Simona Maria
Jolidon Synese
Pinard Emmanuel
Thomas Andrew William
Aulakh Charanjit S.
Hoffmann-La Roche Inc.
Johnston George W.
Prior Kimberly J.
Rocha-Tramaloni Patricia S.
LandOfFree
Diaza-spiropiperidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diaza-spiropiperidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diaza-spiropiperidine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3882537